These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 36978495)

  • 1. Design and Synthesis of Novel Antimicrobial Agents.
    Breijyeh Z; Karaman R
    Antibiotics (Basel); 2023 Mar; 12(3):. PubMed ID: 36978495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoparticle-peptide conjugates for bacterial detection and neutralization: Potential applications in diagnostics and therapy.
    Gonçalves S; Martins IC; Santos NC
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Nov; 14(6):e1819. PubMed ID: 36416027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nano-Strategies to Fight Multidrug Resistant Bacteria-"A Battle of the Titans".
    Baptista PV; McCusker MP; Carvalho A; Ferreira DA; Mohan NM; Martins M; Fernandes AR
    Front Microbiol; 2018; 9():1441. PubMed ID: 30013539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Demand for New Antibiotics: Antimicrobial Peptides, Nanoparticles, and Combinatorial Therapies as Future Strategies in Antibacterial Agent Design.
    León-Buitimea A; Garza-Cárdenas CR; Garza-Cervantes JA; Lerma-Escalera JA; Morones-Ramírez JR
    Front Microbiol; 2020; 11():1669. PubMed ID: 32793156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repurposing Non-Antibiotic Drugs Auranofin and Pentamidine in Combination to Combat Multidrug-Resistant Gram-Negative Bacteria.
    Yu Y; Zhao H; Lin J; Li Z; Tian G; Yang YY; Yuan P; Ding X
    Int J Antimicrob Agents; 2022 May; 59(5):106582. PubMed ID: 35378227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breaking antimicrobial resistance by disrupting extracytoplasmic protein folding.
    Furniss RCD; Kaderabkova N; Barker D; Bernal P; Maslova E; Antwi AAA; McNeil HE; Pugh HL; Dortet L; Blair JMA; Larrouy-Maumus G; McCarthy RR; Gonzalez D; Mavridou DAI
    Elife; 2022 Jan; 11():. PubMed ID: 35025730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug-resistant gram-negative organisms: a review of recently approved antibiotics and novel pipeline agents.
    Provenzani A; Hospodar AR; Meyer AL; Leonardi Vinci D; Hwang EY; Butrus CM; Polidori P
    Int J Clin Pharm; 2020 Aug; 42(4):1016-1025. PubMed ID: 32638294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic resistant bacteria: current situation and treatment options to accelerate the development of a new antimicrobial arsenal.
    Tarín-Pelló A; Suay-García B; Pérez-Gracia MT
    Expert Rev Anti Infect Ther; 2022 Aug; 20(8):1095-1108. PubMed ID: 35576494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanotechnology as a Novel Approach in Combating Microbes Providing an Alternative to Antibiotics.
    Mubeen B; Ansar AN; Rasool R; Ullah I; Imam SS; Alshehri S; Ghoneim MM; Alzarea SI; Nadeem MS; Kazmi I
    Antibiotics (Basel); 2021 Nov; 10(12):. PubMed ID: 34943685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Neutrally Charged Diarylurea Compound PQ401 Kills Antibiotic-Resistant and Antibiotic-Tolerant Staphylococcus aureus.
    Kim W; Zou G; Pan W; Fricke N; Faizi HA; Kim SM; Khader R; Li S; Lee K; Escorba I; Vlahovska PM; Gao H; Ausubel FM; Mylonakis E
    mBio; 2020 Jun; 11(3):. PubMed ID: 32605985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanotechnology as a Promising Approach to Combat Multidrug Resistant Bacteria: A Comprehensive Review and Future Perspectives.
    Hetta HF; Ramadan YN; Al-Harbi AI; A Ahmed E; Battah B; Abd Ellah NH; Zanetti S; Donadu MG
    Biomedicines; 2023 Jan; 11(2):. PubMed ID: 36830949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial Nosocomial Infections: Multidrug Resistance as a Trigger for the Development of Novel Antimicrobials.
    Sousa SA; Feliciano JR; Pita T; Soeiro CF; Mendes BL; Alves LG; Leitão JH
    Antibiotics (Basel); 2021 Aug; 10(8):. PubMed ID: 34438992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial Resistance and Recent Alternatives to Antibiotics for the Control of Bacterial Pathogens with an Emphasis on Foodborne Pathogens.
    Helmy YA; Taha-Abdelaziz K; Hawwas HAE; Ghosh S; AlKafaas SS; Moawad MMM; Saied EM; Kassem II; Mawad AMM
    Antibiotics (Basel); 2023 Jan; 12(2):. PubMed ID: 36830185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent antibacterial carbohydrate-based prodrugs, drugs and delivery systems to overcome antimicrobial resistance.
    Maria C; de Matos AM; Rauter AP
    Curr Opin Chem Biol; 2024 Feb; 78():102419. PubMed ID: 38219399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of Antimicrobial Peptides of the Innate Immune System in Combination With Conventional Antibiotics-A Novel Way to Combat Antibiotic Resistance?
    Zharkova MS; Orlov DS; Golubeva OY; Chakchir OB; Eliseev IE; Grinchuk TM; Shamova OV
    Front Cell Infect Microbiol; 2019; 9():128. PubMed ID: 31114762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial Drug Resistance in Poultry Production: Current Status and Innovative Strategies for Bacterial Control.
    Abreu R; Semedo-Lemsaddek T; Cunha E; Tavares L; Oliveira M
    Microorganisms; 2023 Apr; 11(4):. PubMed ID: 37110376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The alarming antimicrobial resistance in ESKAPEE pathogens: Can essential oils come to the rescue?
    Yu Z; Tang J; Khare T; Kumar V
    Fitoterapia; 2020 Jan; 140():104433. PubMed ID: 31760066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Research Progress of Anti-Drug Resistant Bacteria Drugs.
    Infect Drug Resist; ; . PubMed ID: 34992385
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.